About Dr. Wang Congjun
Dr. Wang Congjun is a Chief Physician (主任医师) in the Department of Hepatobiliary and Pancreatic Surgery at Renji Hospital, affiliated with Shanghai Jiao Tong University School of Medicine. With extensive experience in pancreatic cancer, periampullary carcinoma, and complex hepatobiliary-pancreatic-splenic surgery, Dr. Wang is a trusted specialist for patients facing some of the most technically demanding operations in abdominal oncology.
Dr. Wang's clinical practice spans the full spectrum of upper abdominal surgical oncology, with a particular focus on tumors of the pancreas, ampulla of Vater, bile duct, and surrounding structures. His expertise in periampullary carcinoma — a group of cancers that includes ampullary cancer, distal cholangiocarcinoma, and duodenal cancer in addition to pancreatic head cancer — reflects a nuanced understanding of the anatomical and oncological complexity of this region.
Clinical Expertise
- Pancreatic cancer surgery — pancreaticoduodenectomy (Whipple procedure), distal pancreatectomy, and total pancreatectomy for pancreatic head, body, and tail tumors
- Periampullary carcinoma — surgical management of ampullary cancer, distal cholangiocarcinoma, and duodenal adenocarcinoma, which share the Whipple procedure as the primary curative operation
- Complex hepatobiliary surgery — liver resections, bile duct reconstructions, and combined hepatopancreatic procedures for locally advanced or multifocal disease
- Splenic surgery — splenectomy and spleen-preserving distal pancreatectomy, balancing oncological adequacy with organ preservation where appropriate
- Biliary reconstruction — hepaticojejunostomy and other biliary bypass procedures for obstructive jaundice caused by pancreatic or biliary tumors
- Multidisciplinary treatment coordination — working within Renji Hospital's HPB tumor board to integrate surgery with chemotherapy, targeted therapy, and interventional radiology
Why Dr. Wang Congjun?
Periampullary cancers are a group of malignancies that require a surgeon with deep familiarity with the complex anatomy of the pancreatic head, bile duct, and duodenum. The Whipple procedure — the standard operation for these tumors — is one of the most technically demanding operations in abdominal surgery, and outcomes are strongly correlated with surgeon and center volume. Dr. Wang's experience at Renji Hospital, one of Shanghai's highest-volume HPB centers, ensures that patients receive care from a team that performs these operations routinely.
For patients with complex hepatobiliary-pancreatic-splenic disease — including those with tumors involving multiple adjacent organs or requiring combined resections — Dr. Wang's breadth of surgical expertise across the entire upper abdomen is a significant advantage. His ability to manage the full anatomical complexity of these cases in a single operative setting reduces the need for staged procedures and simplifies the patient's overall treatment journey.
Hospital: Renji Hospital, Shanghai Jiao Tong University School of Medicine
Renji Hospital is one of Shanghai's most prestigious academic medical centers, with over 160 years of history and a strong international reputation in hepatobiliary surgery, oncology, and organ transplantation. The hospital's HPB surgery department handles a high volume of complex referral cases from across China and internationally, supported by advanced imaging, interventional radiology, and a dedicated surgical ICU. Renji's multidisciplinary tumor board meets regularly to review challenging HPB cases, ensuring coordinated, evidence-based treatment planning for every patient.
About Periampullary & Pancreatic Cancer
Periampullary cancers — those arising near the ampulla of Vater where the bile duct and pancreatic duct meet the duodenum — include four distinct tumor types with different prognoses:
- Pancreatic ductal adenocarcinoma (PDAC): the most common and aggressive, with a 5-year survival of 10–25% after resection
- Ampullary carcinoma: better prognosis, with 5-year survival of 30–50% after Whipple resection
- Distal cholangiocarcinoma: intermediate prognosis, 5-year survival of 20–40% after resection
- Duodenal adenocarcinoma: relatively favorable, 5-year survival of 40–60% after resection
All four tumor types are treated with the pancreaticoduodenectomy (Whipple procedure) as the primary curative operation. Accurate preoperative diagnosis — distinguishing between these tumor types — is important for counseling patients on prognosis and planning adjuvant therapy. Key considerations for international patients:
- Obstructive jaundice (yellow skin, dark urine, pale stools) is the most common presenting symptom and often prompts the initial diagnosis
- Endoscopic retrograde cholangiopancreatography (ERCP) with biliary stenting may be performed to relieve jaundice before surgery
- CA 19-9 and CEA are the primary tumor markers; bilirubin and liver function tests are monitored closely
- Adjuvant chemotherapy (gemcitabine + capecitabine, or FOLFIRINOX) is recommended after resection for pancreatic cancer
What to Prepare Before Your Consultation
To facilitate a remote case review with Dr. Wang's team, international patients should prepare:
- CT scan of the abdomen and pelvis with contrast (DICOM format, within 3 months)
- MRI/MRCP for biliary and pancreatic duct assessment
- Pathology report and biopsy or cytology results if available
- CA 19-9, CEA, bilirubin, and liver function test results
- Summary of prior treatments and response assessments
- Current medications, especially anticoagulants or diabetes management
How CMCS Can Help
China Medical Concierge Shanghai (CMCS) coordinates access to Dr. Wang Congjun and the Renji Hospital HPB surgery team for international patients. Our services include:
- Remote case review and pre-consultation assessment before you travel
- Priority appointment scheduling with Dr. Wang's team
- Full translation of medical records, imaging reports, and treatment plans
- In-hospital accompaniment by a dedicated English-speaking case manager
- Accommodation, airport transfer, and logistics coordination in Shanghai
- Post-discharge follow-up and remote consultation support
Contact us to begin your case review:
📧 contract@medicalsh.com
💬 WhatsApp: https://wa.me/message/3AM6KAGCW2BAD1
🌐 www.medicalsh.com
0 Kommentare